AU1790988A - Phosphoethanolamine for treatment of alzheimer's disease - Google Patents

Phosphoethanolamine for treatment of alzheimer's disease

Info

Publication number
AU1790988A
AU1790988A AU17909/88A AU1790988A AU1790988A AU 1790988 A AU1790988 A AU 1790988A AU 17909/88 A AU17909/88 A AU 17909/88A AU 1790988 A AU1790988 A AU 1790988A AU 1790988 A AU1790988 A AU 1790988A
Authority
AU
Australia
Prior art keywords
phosphoethanolamine
alzheimer
disease
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU17909/88A
Inventor
Stanley H. Appel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baylor College of Medicine
Original Assignee
Baylor College of Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baylor College of Medicine filed Critical Baylor College of Medicine
Publication of AU1790988A publication Critical patent/AU1790988A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU17909/88A 1987-05-19 1988-05-18 Phosphoethanolamine for treatment of alzheimer's disease Abandoned AU1790988A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US5189787A 1987-05-19 1987-05-19
US051897 1987-05-19
US18800588A 1988-05-11 1988-05-11
US188005 1988-05-11

Publications (1)

Publication Number Publication Date
AU1790988A true AU1790988A (en) 1988-12-21

Family

ID=26729929

Family Applications (1)

Application Number Title Priority Date Filing Date
AU17909/88A Abandoned AU1790988A (en) 1987-05-19 1988-05-18 Phosphoethanolamine for treatment of alzheimer's disease

Country Status (3)

Country Link
AU (1) AU1790988A (en)
IL (1) IL86423A0 (en)
WO (1) WO1988009171A1 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6723699B1 (en) 1989-06-05 2004-04-20 Cephalon, Inc. Treating disorders by application of insulin-like growth factors and analogs
US6693076B1 (en) 1989-06-05 2004-02-17 Cephalon, Inc. Treating disorders by application of insulin-like growth factors and analogs
US5652214A (en) * 1989-06-05 1997-07-29 Cephalon, Inc. Treating disorders by application of insulin-like growth factors and analogs
US6407061B1 (en) 1989-12-05 2002-06-18 Chiron Corporation Method for administering insulin-like growth factor to the brain
US5624898A (en) 1989-12-05 1997-04-29 Ramsey Foundation Method for administering neurologic agents to the brain
US5760021A (en) * 1992-05-29 1998-06-02 The Procter & Gamble Company Phosphonocarboxylate compounds pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism
US20040208875A1 (en) 1995-03-15 2004-10-21 Queen's University At Kingston Method for treating amyloidosis
DK1060750T3 (en) * 1993-03-29 2006-01-09 Univ Kingston Propane-1,3-disulfonic acid and its pharmaceutically acceptable salts for the treatment of amyloidosis
US6008188A (en) * 1994-05-06 1999-12-28 Kanebo Limited Cytokine potentiator and pharmaceutical formulation for cytokine administration
WO1999004781A1 (en) * 1997-07-28 1999-02-04 The Institute Of Physical And Chemical Research Protecting and survival promoting agent for central nervous cell
US7273618B2 (en) 1998-12-09 2007-09-25 Chiron Corporation Method for administering agents to the central nervous system
IL131334A0 (en) * 1999-08-10 2001-01-28 Yeda Res & Dev Pharmaceutical compositions comprising hydroxyamines
US7226916B1 (en) 2000-05-08 2007-06-05 N.V. Nutricia Preparation for the prevention and/or treatment of vascular disorders
US7115585B2 (en) * 2000-08-21 2006-10-03 Inspire Pharmaceuticals, Inc. Compositions for treating epithelial and retinal tissue diseases
US7714020B2 (en) 2001-05-24 2010-05-11 Neuren Pharmaceuticals Limited Treatment of non-convulsive seizures in brain injury using G-2-methyl-prolyl glutamate
DE60232880D1 (en) 2001-05-24 2009-08-20 Neuren Pharmaceuticals Ltd GPE ANALOGUE AND PEPTIDOMIMETICS
US7605177B2 (en) 2001-05-24 2009-10-20 Neuren Pharmaceuticals Limited Effects of glycyl-2 methyl prolyl glutamate on neurodegeneration
AU2005326962A1 (en) 2004-12-22 2006-08-17 Bellus Health (International) Limited Methods and compositions for treating amyloid-related diseases
WO2007125385A2 (en) 2005-12-22 2007-11-08 Neurochem (International) Limited Treatment of renal disorders, diabetic nephopathy and dyslipidemias
SI2089417T1 (en) 2006-10-12 2015-04-30 Bhi Limited Partnership Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
CN114099487A (en) * 2021-12-22 2022-03-01 上海市第一人民医院 Application of ethanolamine in preparation of product for preventing, relieving and/or treating neuroinflammation related diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2437834A1 (en) * 1978-10-04 1980-04-30 Lejeune Jerome L-serine or glycine for treatment of cerebral deficiencies - such as mongolism and general mental debility, etc.
US4569929A (en) * 1980-02-29 1986-02-11 Massachusetts Institute Of Technology Cytidyl diphosphocholine-drug composition
US4386078A (en) * 1980-03-03 1983-05-31 The Ohio State University Research Foundation Therapeutic agents for preventing phospholipid degradation and free fatty acid proliferation

Also Published As

Publication number Publication date
WO1988009171A1 (en) 1988-12-01
IL86423A0 (en) 1988-11-15

Similar Documents

Publication Publication Date Title
AU1790988A (en) Phosphoethanolamine for treatment of alzheimer's disease
AU8392291A (en) Tachykinin agonists for treatment of alzheimer's disease
AP9000206A0 (en) Treatment of conditions & diseases
AU2414092A (en) Diagnostic method for alzheimer's disease
ZA829335B (en) Pharmaceutical preparation for treating alzheimer's disease
EP0799617A3 (en) Therapeutic agent for neurological diseases
AU6905391A (en) Methods and compositions for the treatment of hodgkin's disease
AU1808488A (en) Compounds for the treatment of alzheimer's disease
EP0331620A3 (en) Agent for the treatment of parkinson's disease
AU4759390A (en) Method of medical treatment of alzheimer's disease
AU4524889A (en) Method for the treatment of periodontal disease
AU7556994A (en) Methods for the diagnosis of alzheimer's disease
HU892994D0 (en) Process for the production of stabil medical preparations
AU2787889A (en) Test for johne's disease
HU911750D0 (en) Process for the production of medical preparations containing substituted betha-hydroxy-ethylamines
AU5053296A (en) Pharmaceutical agents for the treatment of Alzheimer's disease
HU9102385D0 (en) Process for the production of medical preparations
FR2616831B1 (en) ALVEOLAR-TYPE STRUCTURE FOR THE BURIAL OF HUMAN REMAINS
AU8185491A (en) Treatment of disease
AU1807592A (en) New combination preparation for treatment of parkinson's disease
CS22891A2 (en) Application of benzylphosphonic acid's derivatives for treatment of virusinduced diseases
HU908272D0 (en) Process for the production of medical preparations for external treatment
GB2210040B (en) The new process for the preparation of 3-(4'-bromobiphenyl-4-yl) tetralin-1-one
AU2207188A (en) Device for treatment of gum disease
FR2610924B1 (en) PROCESS FOR THE PREPARATION OF HYDROXYBIPHENYLES